A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid...

Aridis Pharmaceuticals is taking on the challenge of making an inhaled monoclonal antibody to treat COVID.

Planning for a post pandemic era using AI tools will give patients quicker access to scarce capacity and drive up medical staff satisfaction

Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates

The mission of UpHealth and their related companies is to provide high quality, affordable and accessible care to people around the world.

Derek Maetzold, President and CEO of Castle Biosciences is harnessing the power of genomics to understand the biology of skin cancer.